ImVitro, a Paris, France-based provider of a B2B SaaS platform that applies computer vision and artificial intelligence to the IVF fertility imaging process, raised $2.5m in seed funding.
The round was led by LDV Capital, with participation from MMC Ventures, Tiny VC, Fly Ventures, and Compound VC.
The company intends to use the funds to add key hires across technical and sales teams, expand to the U.S. market, and develop additional features to their software to keep saving clinicians’ time. `
Led by Dr. Alexandra Boussommier, Founder and CEO, ImVitro has developed a B2B SaaS platform, called EMBRYOLY, that applies computer vision to the IVF fertility imaging process to improve the IVF journey by automating some of its key decision-making. ImVitro analyzes over 30 clinical data points to create a hybrid score that includes the patient’s BMI, uterus receptivity, spermatozoa mobility, and more to improve accuracy and help personalize and standardize results and KPIs. With ImVitro, clinics can also grant access to their patients to a patient portal to deliver simplified lab results. More than a dozen clinics across Europe are using it routinely in their labs.
The company also has an office in London, UK and in 2023 considers opening an office in Spain.
FinSMEs
05/12/2022